A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/08/2011	US20110300120 Oligosaccharide-protein conjugates
12/08/2011	US20110300115 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence
12/08/2011	US20110300109 Compositions and methods for treating cancer
12/08/2011	US20110300105 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
12/08/2011	US20110300104 Hepatitis c virus inhibitors
12/08/2011	US20110300103 Heterocyclic antiviral compounds
12/08/2011	US20110300102 Composition for skin regeneration, containing a secretion in the culture of an embryonic stem cell-derived endothelial progenitor cell or fractions thereof, and use thereof
12/08/2011	US20110300101 Methods for treating viral infection using IL-28 and IL-29 Cysteine mutants
12/08/2011	US20110300100 Il-11 muteins
12/08/2011	US20110300099 Multi-level specific targeting of cancer cells
12/08/2011	US20110300098 Methods of treating cancer using il-21 and monoclonal antibody therapy
12/08/2011	US20110300097 Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
12/08/2011	US20110300066 Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
12/08/2011	DE102010023837A1 Isolierung von mesenchymalen Stammzellen Isolation of mesenchymal stem cells
12/08/2011	CA2805270A1 Treatment of inflammatory disorders
12/08/2011	CA2801579A1 Methods for treatment of nephrotic syndrome and related conditions
12/08/2011	CA2801240A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	CA2801237A1 Rhamm binding peptides
12/08/2011	CA2801167A1 Xyxin fragment biomarker for diagnosis of colon cancer
12/08/2011	CA2801162A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	CA2801129A1 Fraction of proteins and peptides derived from egg white and protein derived from egg white and use thereof as anti-listeria agent
12/08/2011	CA2801120A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2801116A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2800417A1 A pharmaceutical composition for topical application comprising a mitogenic agent in combination with one or more bactericidal and bacteriostatic agents
12/08/2011	CA2800281A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	CA2800153A1 Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications
12/08/2011	CA2799066A1 Method for cancer therapy
12/08/2011	CA2793601A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1
12/07/2011	EP2392660A2 ENA Nucleic Acid Drugs Modifying Splicing in mRNA Precursor
12/07/2011	EP2392647A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/07/2011	EP2392646A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/07/2011	EP2392645A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP2392591A1 DNA sequence and recombinant creation of grass pollen allergen Phl p 4
12/07/2011	EP2392587A1 Peptide sequences and compositions
12/07/2011	EP2392586A1 Binding peptidomimetics and uses of the same
12/07/2011	EP2392585A2 Scaffold proteins for recombinant peptide aptamers
12/07/2011	EP2392350A1 Methods for treating conditions associated with MASP-2 dependent complement activation
12/07/2011	EP2392344A1 Suture line administration technique using botulinum toxins
12/07/2011	EP2392343A1 Antimicrobial composition and uses thereof
12/07/2011	EP2392342A1 Compositions for use in the treatment or diagnosis of prion diseases
12/07/2011	EP2392341A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392330A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392329A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392317A1 Counter-pressure filtration of proteins
12/07/2011	EP2391649A1 Tslp promotes immune evasion and persistence of viruses
12/07/2011	EP2391648A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques
12/07/2011	EP2391646A1 Crystalline insulin-conjugates
12/07/2011	EP2391645A1 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
12/07/2011	EP2391644A2 Conformationally dynamic peptides
12/07/2011	EP2391641A2 Novel peptides and methods for producing them
12/07/2011	EP2391630A2 Anti-cancer protein-platinum conjugates
12/07/2011	EP2391382A1 Pharmaceutical preparation comprising lipase of bacterial origin
12/07/2011	EP2391381A1 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
12/07/2011	EP2391380A2 Polynucleotide aptamer-based cross -linked materials and uses thereof
12/07/2011	EP2391379A1 Compound and method for treatment of alzheimer's disease
12/07/2011	EP2391378A1 Use of a fragment of rasgap peptide in the treatment or prevention of metastasis
12/07/2011	EP2391377A2 Peptides, pharmaceutical compositions comprising same and uses thereof
12/07/2011	EP2391376A1 Cyclosporin analogues for preventing or treating hepatitis c infection
12/07/2011	EP2391331A1 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
12/07/2011	EP2391229A1 Functional food product comprising heat shock protein or a hydrolysate thereof
12/07/2011	EP2391225A1 Method for production of lactoferrin
12/07/2011	EP2391216A1 Exogenously triggered controlled release materials and uses thereof
12/07/2011	EP2391215A1 Binding-site modified lectins and uses thereof
12/07/2011	EP2190304B1 Nutritional formulation with high energy content
12/07/2011	EP2158319B1 Bone targeted alkaline phosphatase, kits and methods of use thereof
12/07/2011	EP2086998B1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
12/07/2011	EP2084178B1 Peptide-cytotoxic conjugates
12/07/2011	EP1799701B1 Peptide inhibitors of hk2 and their use.
12/07/2011	EP1718323B1 Binding peptidomimetics and uses of the same
12/07/2011	EP1667521B1 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
12/07/2011	EP1457558B1 Weed controller metabolism proteins, genes thereof and use of the same
12/07/2011	EP1450605B1 Composition to alter bone properties in a subject
12/07/2011	EP1141248B1 A method for the high level expression of the active form of lymphotoxin-beta receptor immunoglobulin fusion proteins and their purification
12/07/2011	CN1843504B 一种白蛋白毫微球组合药物及其制备和使用方法 One kind of albumin nanospheres combination of drugs and their preparation and use
12/07/2011	CN1527698B 控释可生物降解的凝胶基质 Controlled release biodegradable gel matrix
12/07/2011	CN102272289A 用于活化干细胞的方法和装置 Activation of stem cells for a method and apparatus
12/07/2011	CN102272163A 瘦素和瘦素类似物结合物及其用途 Leptin and analogue conjugates and their use
12/07/2011	CN102272151A Crhr2肽激动剂及其用途 Crhr2 peptide agonists and their uses
12/07/2011	CN102272150A 新的抗衰老肽及含有所述肽的化妆品和/或药物组合物 The new peptides and anti-aging cosmetic and / or pharmaceutical compositions containing the peptide
12/07/2011	CN102272149A 新的抗衰老肽及含有所述肽的化妆品和/或药物组合物 The new peptides and anti-aging cosmetic and / or pharmaceutical compositions containing the peptide
12/07/2011	CN102271703A 用于治疗补体相关障碍的方法和组合物 For the treatment of complement-associated disorders The methods and compositions
12/07/2011	CN102271701A 具有脂类动员性质的糖蛋白及其治疗用途 Glycoprotein lipid mobilizing its therapeutic use have properties
12/07/2011	CN102271700A 用于促进甲生长的环孢菌素组合物 Used to promote the growth of cyclosporin A composition
12/07/2011	CN102271699A 用于治疗hcv和hiv感染的环孢菌素衍生物 Cyclosporin derivatives for the treatment of hcv and hiv infection
12/07/2011	CN102271688A 用于治疗hcv的环孢菌素衍生物和核苷的组合 Compositions for treating hcv cyclosporin derivatives and nucleosides
12/07/2011	CN102271658A 用于治疗伤口、瘢痕、外科手术后粘连形成的含有透明质酸的组合物 For treating wounds, scars, the composition comprising hyaluronic acid adhesion formation following surgery
12/07/2011	CN102271499A 用于向脑死亡的、心脏搏动的潜在器官供者施用的包含去甲肾上腺素和net抑制剂的组合物 For the death of the brain, the heart beat of the potential organ donor comprises administering norepinephrine and net inhibitor composition
12/07/2011	CN102269766A 人类基因fam96a及其蛋白质的应用 Human genes and proteins applications fam96a
12/07/2011	CN102268423A 一种放射性铼标记人纤溶酶原kringle5蛋白及其制备方法 A radioactive rhenium labeled human plasminogen kringle5 protein and its preparation method
12/07/2011	CN102268422A 一种可抑制hiv-1反转录酶的蝉花蛋白酶及制备方法 That inhibits hiv-1 reverse transcriptase and protease preparation cicadae
12/07/2011	CN102268414A 具有抗肿瘤细胞增殖活性的毛头鬼伞漆酶及其制备方法 Proliferative activity has comatus laccase and anti-tumor cell preparation
12/07/2011	CN102268094A Modified transferrin fusion proteins
12/07/2011	CN102268093A 一种肝靶向肽与人干扰素a2b融合蛋白及其制备方法和应用 One kind of liver targeting peptide fusion protein with human interferon a2b its preparation method and application
12/07/2011	CN102268085A 重组细胞球蛋白在延缓皮肤衰老中的应用 Globulin used in recombinant cells in aging skin
12/07/2011	CN102268084A 一种软黄金胶原蛋白的制备方法和功能研究 Preparation of a soft gold collagen and functional studies
12/07/2011	CN102268083A 脱端基纤维蛋白原及其制备方法和应用 Off the end groups of fibrinogen and its preparation method and application
12/07/2011	CN102268079A 猪瘟病毒csfv e2蛋白配体表位多肽及其应用 Csfv e2 with classical swine fever virus surface protein polypeptides and its application
12/07/2011	CN102268077A 鸡传染性法氏囊病病毒ibdv vp2蛋白配体结合表位多肽及其应用 Infectious bursal disease virus ibdv vp2 protein ligand binding epitope peptide and its application
12/07/2011	CN102268075A Glycopeptide drug-fast bacteria resisting antibiotic as well as preparation method and application thereof

1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 3163